Clearmind Medicine to Pursue Dual Listing on Nasdaq
Toronto, Ontario, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTC Pink: CMNDF), (“Clearmind” or...
Month: November 2021
Former CPO of Convoy and Marchex Joins H1 as Chief Operating Officer
Ziad Ismail Joins H1 During Period of High Growth for Leading Global Healthcare Network Ziad Ismail, COO of H1 Former...
Zealand Pharma announces successful outcome of Phase 1b clinical trial with GLP1-GLP2 dual receptor agonist, dapiglutide
Company announcement – No. 70 / 2021 Zealand Pharma announces successful outcome of Phase 1b clinical trial with GLP1-GLP2 dual receptor agonist,...
Allied Corp Signs Contract for the Sale of Retail Ready Products Into Mexico
KELOWNA, British Columbia, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
Auxly Acquires 100% Ownership of Sunens and Amends Credit Facility
Sunens Farms The state-of-the-art Sunens facility, acquired by Auxly Cannabis Group. Auxly acquires remaining equity interest and secures 100% ownership...
RespireRx Pharmaceuticals Inc. Announces CEO’s OTC Venture Market Podcast
Glen Rock, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI), (“RespireRx” or the “Company”) a leader...
Promising COVID-19 Therapeutic Drug to start Phase 3 Clinical Trial in the United States
Pulmonem and the Research Institute of the McGill University Health Centre announce recruitment of first US-based patientsDIEPPE, New Brunswick, Nov....
CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX110™ for the Treatment of Relapsed or Refractory CD19+ B-cell malignancies
ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on...
Achieve Life Sciences Announces Phase 3 ORCA-2 Trial of Cytisinicline in Smoking Cessation Clears Final Review by Data Safety Monitoring Committee (DSMC)
Following the fifth and final DSMC review, committee has concluded no concerns with cytisinicline safety or Phase 3 trial conductSEATTLE,...
Sharps Compliance Adds Transportation Industry Veteran Gary R. Enzor to Board of Directors
HOUSTON, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national...
POINT Biopharma to Host Virtual Education Event on December 6, 2021
POINT to host inaugural educational event highlighting radiopharmaceuticals, their therapeutic benefit, and commercial considerations Register online at https://hub.pointbiopharma.com/dec2021 INDIANAPOLIS, Nov....
180 Life Sciences Corp. Expands Patent Portfolio
New IP Relates to a Method for Treating Chronic Pain or Associated Conditions/Symptoms with Novel Compositions Including Certain Phenyl Substituted...
Todos Medical Receives Purchase Order for 50,000 Bottles of Tollovid Daily from Its European Distribution Partner T-Cell Protect Hellas S.A for Initial Market Launch in Greece
· T-Cell Protect is also evaluating expected demand for maximum strength Tollovid® New York, NY, and Tel Aviv, ISRAEL, Nov. 22,...
Seer to Participate in the Piper Sandler Virtual Healthcare Conference
REDWOOD CITY, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive...
Shockwave Medical Enrolls First Patient in Disrupt BTK II Study for Long, Calcified, Below the Knee Lesions
Global Post-Market Study Will Assess Long-Term Benefit of Peripheral IVL on the Most Challenging Calcified Lesions, Including Patients with Critical...
Akoya Biosciences to Host Inaugural Spatial Day on December 15, 2021
The program will highlight the latest breakthroughs and applications in spatial biology and the company’s latest innovations to accelerate breakthroughs...
Cue Biopharma to Present at the Piper Sandler 33rd Annual Healthcare Conference
CAMBRIDGE, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel...
Antares Pharma to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
EWING, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today...
PMV Pharma to Present at the Evercore ISI 4th Annual HealthCONx Conference
CRANBURY, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery...
Alignment Healthcare to Participate in Upcoming Piper Sandler Investor Conference
ORANGE, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (Nasdaq: ALHC), a mission-based,...
